The total return over the past 12 months is +182.36% vs. +16.94% for the S&P 500. So far it's up +153.98% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +182.36% | +23.46% | (31.75%) | N/A | N/A | N/A |
| Total Return CAGR | +182.36% | +23.46% | (31.75%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Faeth Therapeutics, Inc. (FTH)
| Year | Start price | End price | FTH Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $10.67 | $27.10 | +153.98% | +14.51% | +139.47% |
| 2025 | $9.80 | $10.67 | +8.88% | +17.72% | (8.84%) |
| 2024 | $13.84 | $9.80 | (29.19%) | +24.89% | (54.08%) |
| 2023 | $29.80 | $13.84 | (53.56%) | +26.19% | (79.75%) |
| 2022 | $116.00 | $29.80 | (74.31%) | (18.17%) | (56.14%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
